Buy Zeta Global Holdings Corp. (ZETA) as a compelling medium-term growth play, supported by its proprietary global tracking moat, enterprise-level AI partnerships, and an attractive valuation relative to its rapid expansion. Accumulate TransMedics Group, Inc. (TMDX) for long-term turnaround potential as it targets $2 billion in revenue by 2032, though investors should remain cautious of near-term Medicare reimbursement risks. Position in SoFi Technologies, Inc. (SOFI) as a leveraged trade on lower interest rates, where a drop in borrowing costs could trigger a major valuation re-rating. Monitor digital credit instruments like STRC and MicroStrategy (MSTR) for recovery plays as Bitcoin sentiment stabilizes and Treasury yields decline.

Zeta Global Holdings Corp. (ZETA)

• Reported an outstanding performance with its 20th consecutive beat and raise quarter, sending the stock up 26% over a five-year/five-day tracking period mentioned in the transcript
• Developed a core moat by establishing a new method of tracking approximately 535 million people globally for targeted marketing following Apple's privacy and cookie updates
• Backed by notable partnerships including Palantir, Snowflake, and OpenAI, alongside the ongoing rollout of AI-driven products like Athena and Zeta Business Intelligence
• Targets top-tier enterprise clients first before expanding to small and medium-sized businesses, mirroring Palantir's early growth strategy
• Described as very cheap relative to its growth, holding an enterprise value over gross profit over revenue growth (EV/GP/RG) of 0.2 and a Rule of 40 score of 61

Takeaways

• Consider Zeta as a compelling medium-term growth opportunity due to its unique tracking moat, strong enterprise partnerships, and attractive valuation metrics compared to other software and AI plays

TransMedics Group, Inc. (TMDX)

• Experienced a mixed quarter with the stock down 42% over a six-month period, currently sitting in a "valley of despair" despite holding a game-changing organ care system that extends the viability of organ transplants
• Updated its long-term guidance to a target of 30,000 transplants and $2 billion in revenue by 2032, up from previous targets, against current revenues of $669 million
• Valuation is considered reasonable with an EV/GP/RG of 0.3 and a Rule of 40 score of 52
• Faces key risk factors including uncertainties around CMS (Medicare) price reimbursements, clinical trial questions, aviation costs, and international expansion timelines into Europe

Takeaways

• Exercise caution if heavily reliant on government reimbursement models, but keep an eye on TransMedics for long-term turnaround potential if management continues to deliver on its predictable multi-year growth targets

SoFi Technologies, Inc. (SOFI)

• Displayed strong underlying fundamentals with consistent growth across members, revenue, products sold, and platform engagement, alongside a dozen consecutive quarters of raised outlooks
• Trades inversely with interest rates and the 10-year Treasury yield, leading to suppressed stock performance despite robust business execution
• Management's guidance models two rate hikes in 2026, though the speaker anticipates potential macroeconomic resistance to rate hikes prior to midterms
• Appears undervalued with an EV/GP/RG of 0.21 and a Rule of 40 score of 67

Takeaways

• View SoFi as a leveraged play on lower interest rates; a significant drop in borrowing costs could drive a major re-rating and massive surge in personal loan demand and price appreciation

MicroStrategy & Associated Digital Credit Instruments (MSTR / STRC)

• Mentioned that preferred digital credit instruments like STRC are bouncing back toward 100 (hitting around 94 during the reporting period) after experiencing a dip into the 70s during a recent market sell-off
• Recovery is driven by a rebound in Bitcoin, improving fear and greed metrics moving toward neutral, and a declining 10-year Treasury yield
• Valuations and backing values of these instruments rise as both Bitcoin prices appreciate and macroeconomic interest rates decline

Takeaways

• Monitor digital credit instruments and Bitcoin-adjacent equities as macro indicators like lower interest rates and recovering crypto sentiment align to push credit values back up